Evidence map›Paper›PMID 32807975›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Airmen and health-care providers' attitudes toward the use of genomic sequencing in the US Air Force: findings from the MilSeq Project.

Stacey Pereira, Rebecca L Hsu, Rubaiya Islam, Jill Oliver Robinson, Rishab Ramapriyan, Emily Sirotich, Megan D Maxwell, Mary Majumder, Carrie L Blout, Kurt D Christensen and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stacey PereiraCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA. spereira@bcm.edu.ORCID http://orcid.org/0000-0001-6541-3904
Rebecca L HsuCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
Rubaiya IslamCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
Jill Oliver RobinsonCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
Rishab RamapriyanRice University, Houston, TX, USA.
Emily SirotichDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Megan D MaxwellUniversity Health System, San Antonio, TX, USA.
Mary MajumderCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
Carrie L BloutBrigham and Women's Hospital, Boston, MA, USA.
Kurt D ChristensenHarvard Pilgrim Health Care Institute, Boston, MA, USA.
Maxwell MehlmanLaw-Medicine Center at Case Western University's School of Medicine, Cleveland, OH, USA.
Efthimios ParasidisMoritz College of Law and the College of Public Health, The Ohio State University, Columbus, OH, USA.
Cubby L GardnerDefense Health Headquarters, Falls Church, VA, USA.
Jacqueline M KillianUniformed Services University of the Health Sciences, Bethesda, MD, USA.
Mauricio De CastroAir Force Medical Genetics Center, Keesler AFB, Biloxi, MS, USA.
Robert C GreenBrigham and Women's Hospital, Boston, MA, USA.
MilSeq Project
Amy L McGuireCenter for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.

Funding

Cost-effectiveness of Whole Genome Sequencing of Healthy AdultsK01HG009173 · NHGRI · HARVARD PILGRIM HEALTH CARE, INC. · PI CHRISTENSEN, KURT DEREK · 2016 to 2020
$626k
NHGRI NIH HHS K01 HG009173
6 · The paper itself

Abstract

purposeThe use of genomic sequencing (GS) in military settings poses unique considerations, including the potential for GS to impact service members' careers. The MilSeq Project investigated the use of GS in clinical care of active duty Airmen in the United States Air Force (USAF).

methodsWe assessed perceived risks, benefits, and attitudes toward use of GS in the USAF among patient participants (n = 93) and health-care provider participants (HCPs) (n = 12) prior to receiving or disclosing GS results.

resultsParticipants agreed that there are health benefits associated with GS (90% patients, 75% HCPs), though more HCPs (75%) than patients (40%) agreed that there are risks (p = 0.048). The majority of both groups (67% HCPs, 77% patients) agreed that they trust the USAF with genetic information, but far fewer agreed that genetic information should be used to make decisions about deployment (5% patients, 17% HCPs) or duty assignments (3% patients, 17% HCPs). Despite their hesitancy, patients were supportive of the USAF testing for nondisease traits that could impact their duty performance. Eighty-seven percent of patients did not think their GS results would influence their career.

conclusionResults suggest favorable attitudes toward the use of GS in the USAF when not used for deployment or assignment decisions.

Indexed as

Military PersonnelAttitude of Health PersonnelGenomicsHumansUnited StatesELSIexome sequencinggenomicshealthy populationsmilitary

Identifiers

PMID32807975
PMCPMC7710566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.